Insider Trading Alert - FDS, MJN, WEN, RAI And NATI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 15, 2014, 61 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $15.70 to $288,360,000.00.

Highlighted Stocks Traded by Insiders:

FactSet Research Systems (FDS) - FREE Research Report

Laird Joseph E Jr who is Director at FactSet Research Systems sold 4,500 shares at $107.70 on Jan. 15, 2014. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 4,500-share transaction.

Hadley Philip A who is CEO & Chairman at FactSet Research Systems sold 115,000 shares at $107.61 on Jan. 15, 2014. Following this transaction, the CEO & Chairman owned 839,140 shares meaning that the stake was reduced by 12.05% with the 115,000-share transaction.

The shares most recently traded at $107.51, down $0.10, or 0.09% since the insider transaction. Historical insider transactions for FactSet Research Systems go as follows:

  • 4-Week # shares sold: 833
  • 12-Week # shares sold: 833
  • 24-Week # shares sold: 2,833

The average volume for FactSet Research Systems has been 317,300 shares per day over the past 30 days. FactSet Research Systems has a market cap of $4.6 billion and is part of the technology sector and computer software & services industry. Shares are down 0.86% year-to-date as of the close of trading on Wednesday.

FactSet Research Systems Inc. provides integrated financial information and analytical applications to investment community in the United States, Europe, and the Asia Pacific. The stock currently has a dividend yield of 1.31%. The company has a P/E ratio of 23.7. Currently there are 2 analysts that rate FactSet Research Systems a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FDS - FREE

TheStreet Quant Ratings rates FactSet Research Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full FactSet Research Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Mead Johnson Nutrition Company (MJN) - FREE Research Report

Golsby Stephen W who is Director at Mead Johnson Nutrition Company sold 10,000 shares at $83.12 on Jan. 15, 2014. Following this transaction, the Director owned 90,920 shares meaning that the stake was reduced by 9.91% with the 10,000-share transaction.

The shares most recently traded at $83.99, up $0.87, or 1.03% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition Company go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 20,000
  • 24-Week # shares bought: 10,500
  • 24-Week # shares sold: 50,525

The average volume for Mead Johnson Nutrition Company has been 1.5 million shares per day over the past 30 days. Mead Johnson Nutrition Company has a market cap of $17.0 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 0.32% year-to-date as of the close of trading on Wednesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.62%. The company has a P/E ratio of 27.1. Currently there are 5 analysts that rate Mead Johnson Nutrition Company a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Mead Johnson Nutrition Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Wendy's (WEN) - FREE Research Report

May Peter W who is Director at Wendy's sold 16.2 million shares at $8.90 on Jan. 15, 2014. Following this transaction, the Director owned 66.8 million shares meaning that the stake was reduced by 19.52% with the 16.2 million-share transaction.

Peltz Nelson who is Director at Wendy's sold 16.2 million shares at $8.90 on Jan. 15, 2014. Following this transaction, the Director owned 66.8 million shares meaning that the stake was reduced by 19.52% with the 16.2 million-share transaction.

Garden Edward P who is Director at Wendy's sold 16.2 million shares at $8.90 on Jan. 15, 2014. Following this transaction, the Director owned 66.8 million shares meaning that the stake was reduced by 19.52% with the 16.2 million-share transaction.

Trian Fund Management, L.P. who is 10% Owner at Wendy's sold 32.4 million shares at $8.90 on Jan. 15, 2014. Following this transaction, the 10% Owner owned 66.8 million shares meaning that the stake was reduced by 32.66% with the 32.4 million-share transaction.

The shares most recently traded at $9.16, up $0.26, or 2.84% since the insider transaction. Historical insider transactions for Wendy's go as follows:

  • 4-Week # shares bought: 10,000
  • 12-Week # shares bought: 26,000
  • 24-Week # shares bought: 39,500

The average volume for Wendy's has been 7.5 million shares per day over the past 30 days. Wendy's has a market cap of $3.5 billion and is part of the services sector and leisure industry. Shares are up 3.9% year-to-date as of the close of trading on Wednesday.

The Wendy's Company, through its subsidiaries, owns and franchises Wendy's restaurant system in North America and internationally. It engages in operating, developing, and franchising a system of distinctive quick-service restaurants. The stock currently has a dividend yield of 2.27%. The company has a P/E ratio of 88.1. Currently there are 4 analysts that rate Wendy's a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WEN - FREE

TheStreet Quant Ratings rates Wendy's as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Wendy's Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Reynolds American (RAI) - FREE Research Report

Brown & Williamson Holdings, Inc. who is 10% Owner at Reynolds American sold 155,199 shares at $48.58 on Jan. 15, 2014. Following this transaction, the 10% Owner owned 226.1 million shares meaning that the stake was reduced by 0.07% with the 155,199-share transaction.

The shares most recently traded at $48.52, down $0.06, or 0.12% since the insider transaction. Historical insider transactions for Reynolds American go as follows:

  • 4-Week # shares sold: 129,780
  • 12-Week # shares sold: 890,457
  • 24-Week # shares sold: 2.2 million

The average volume for Reynolds American has been 1.9 million shares per day over the past 30 days. Reynolds American has a market cap of $26.1 billion and is part of the consumer goods sector and tobacco industry. Shares are down 3.26% year-to-date as of the close of trading on Wednesday.

Reynolds American Inc., through its subsidiaries, manufactures and sells cigarette and other tobacco products in the United States. The company operates through RJR Tobacco, American Snuff, and Santa Fe segments. The stock currently has a dividend yield of 5.22%. The company has a P/E ratio of 16.9. Currently there are 2 analysts that rate Reynolds American a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RAI - FREE

TheStreet Quant Ratings rates Reynolds American as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Reynolds American Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

National Instruments Corporation (NATI) - FREE Research Report

Kodosky Jeffrey L who is Director at National Instruments Corporation sold 4,000 shares at $31.75 on Jan. 15, 2014. Following this transaction, the Director owned 971,180 shares meaning that the stake was reduced by 0.41% with the 4,000-share transaction.

The shares most recently traded at $32.44, up $0.69, or 2.13% since the insider transaction. Historical insider transactions for National Instruments Corporation go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 34,271
  • 24-Week # shares sold: 82,271

The average volume for National Instruments Corporation has been 352,600 shares per day over the past 30 days. National Instruments Corporation has a market cap of $4.0 billion and is part of the technology sector and computer software & services industry. Shares are up 1.37% year-to-date as of the close of trading on Wednesday.

National Instruments Corporation designs, manufactures, and sells tools to engineers and scientists worldwide. It offers LabVIEW, a system design software product for measurement and control; and LabVIEW Real-Time and LabVIEW FPGA that are strategic modular software add-ons. The stock currently has a dividend yield of 1.76%. The company has a P/E ratio of 58.0. Currently there is 1 analyst that rates National Instruments Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NATI - FREE

TheStreet Quant Ratings rates National Instruments Corporation as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full National Instruments Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists